Your Top 10 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate‐to‐severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long‐term studies*
Kenji Kabashima, Takayo Matsumura, Hiroshi Komazaki, Makoto Kawashima, for the Nemolizumab JP01 andJP02 Study Group
- Rank
- 4 of 851
- Percentile
- top 0.5%
- Where
- British Journal of Dermatology, 2021
- Citations
- 134
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.